exaluren

Eloxx Pharmaceuticals CEO to Present at Guggenheim Healthcare Innovation Conference

Eloxx Pharmaceuticals CEO Sumit Aggarwal will present at the Guggenheim Healthcare Innovation Conference, discussing progress on exaluren for rare kidney diseases and the ZKN-013 licensing agreement.